Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveAmgen Says Imdelltra Combo Reduced Death Risk 58% in First-Line Lung Cancer

Live News EQUITY FLASH M impact Oct 24, 2026, 02:36 PM UTC

Amgen Says Imdelltra Combo Reduced Death Risk 58% in First-Line Lung Cancer

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

AMGN

Related stories

AstraZeneca Bladder Cancer Treatment Reduced Recurrence Risk 49% Perioperative Imfinzi plus neoadjuvant enfortumab vedotin reduced recurrence risk by 49% and risk of death by 42% in muscle-invasive bladder cancer. M impact | EQUITY | Oct 24, 2026, 02:36 PM UTC AstraZeneca VOLGA Phase III Trial Meets EFS and OS Endpoints AstraZeneca said perioperative Imfinzi plus neoadjuvant enfortumab vedotin met VOLGA Phase III endpoints in MIBC. The trial cut EFS risk by 49% (HR 0.51; p<0.0001) and death risk b M impact | EQUITY | Oct 24, 2026, 02:30 PM UTC Amgen Combination Therapy Cuts Death Risk 58% in Lung Cancer Trial Amgen’s Imdelltra, combined with AstraZeneca’s Imfinzi, reduced the risk of death by 58% versus Imfinzi alone in patients with extensive-stage small cell lung cancer, according to M impact | EQUITY | Oct 24, 2026, 02:30 PM UTC House of Doge Agrees to Acquire McQueen Labs Tokenization Platform and Assets House of Doge announced an agreement to acquire McQueen Labs’ tokenization platform and credit assets. It also plans to investigate financing alternatives and seek stockholder appr M impact | EQUITY | Oct 24, 2026, 01:05 PM UTC Sherritt to Pause Moa Mining as Fuel Constraints Disrupt Operations Sherritt expects to pause mining at its Moa joint venture in Cuba and place the processing plant on standby within the next week for planned maintenance. Fuel delivery resumption t M impact | EQUITY | Oct 24, 2026, 01:05 PM UTC Parabilis Reports 72.2% ORR in Zolucatetide Study; FDA Aligns on Phase 3 Parabilis reported a 72.2% objective response rate (13/18) at doses of at least 450 mg in a 32-week Phase 1/2 analysis of zolucatetide in desmoid tumors. The company said the FDA a M impact | EQUITY | Oct 24, 2026, 12:47 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.